Status | Study |
Recruiting |
Study Name: Systematic Search for Primary Immunodeficiency in Adults With Infections Condition: Complement Deficiency Antibody Deficiency Date: 2016-11-21 Interventions: Biological: Immunological diagnosis tests (Non exhaustive list): hemogram, IgG, A, M, IgG subclasses, co |
Recruiting |
Study Name: Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older Condition: Common Variable Immune Deficiency Specific Antibody Deficiency Date: 2016-10-03 Interventions: Biological: Zostavax® Zostavax® immunization |
Completed |
Study Name: Construction of a Health-related Quality of Life (HR-QOL) Questionnaire for Patients With Primary Antibody Deficiency Disease Condition: Immune Deficiency, Antibody Date: 2015-08-31 Interventions: Other: questionnaire survey The HR-QOL PIDD survey will be administered to the patient by the site PI or |
Recruiting |
Study Name: Polysaccharide Antibody Response Study Condition: Specific Polysaccharide Antibody Deficiency Date: 2015-02-19 Interventions: Biological: Pneumovax 23 (Sanofi Pasteur MSD) |
Completed |
Study Name: A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency Condition: Primary or Secondary Antibody Deficiency (PAD or SAD). Date: 2014-09-02 Interventions: Biological: Vigam® (Human Normal Immunoglobulin) |
Completed |
Study Name: A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam® Condition: Primary Antibody Deficiency. Date: 2014-09-02 Interventions: Biological: Subgam® (Human Normal Immunoglobulin Solution) |
Completed |
Study Name: Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD) Condition: Primary Immune Deficiency Disorder Date: 2013-03-06 Interventions: Biological: RI-002 Immune Globulin Intravenous (IGIV) |
Completed |
Study Name: Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) Condition: Primary Immunodeficiency Agammaglobulinemia Hypogammaglobu Date: 2012-04-16 Interventions: Biological: Kedrion IVIG 10% Dosage form - Intravenous (IV) infusion of Kedrion IVIG 10%; Dosage - 300 t |
Recruiting |
Study Name: Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD) Condition: Primary Immune Deficiency Diseases Date: 2010-08-05 Interventions: Biological: Bacteriophage OX174 Give first dose of bacteriophage (2 x 109 PFU/kg body weight (0.02 ml/kg |
Completed |
Study Name: Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin Condition: Common Variable Immunodeficiency Agammaglobulinemia Date: 2008-04-14 Interventions: Biological: gammaglobulin They were administered a polyvalent, pasteurized liquid immune globulin subcut |